Eli Lilly to Cut Prices of Insulin Drugs by 70%, Cap Patient Costs at $35

Facing pressure to curb diabetes-treatment costs, the company will cut the list prices for its most commonly prescribed insulin and take other steps to make it easier for patients to afford the drugs.

The Wall Street Journal | Compras / Ventas | Farmacia | Jue, 02/03/2023 - 08:23